GlassScriptPhysician profile
Danielle E Leskie
NPI 1669421657
$605.67
in general payments reported to CMS, 2019-2025
25 companies · $43.16 in 2025
The $43.16 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.32 · 2020: $27.98 · 2021: $122 · 2022: $122 · 2023: $146 · 2024: $107 · 2025: $43.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $296.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $116.08 | 2020-2025 | Gardasil 9, Vaxneuvance, Capvaxive |
| Teva Pharmaceuticals USA, INC. | $50.16 | 2020-2022 | |
| Mayne Pharma Commercial LLC | $35.16 | 2023 | |
| Amgen INC. | $32.93 | 2021-2024 | Repatha, Otezla |
| Ultragenyx Pharmaceutical INC. | $32.01 | 2021-2022 | |
| Novo Nordisk INC | $25.39 | 2019-2022 | |
| Lilly USA, LLC | $24.74 | 2021-2023 | Jardiance |
| Abbott Laboratories | $24.37 | 2023 | Freestyle Libre 3 |
| Axsome Therapeutics, INC. | $23.55 | 2025 | Symbravo |
| Organon LLC | $21.23 | 2023 | Nexplanon |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.24 | 2023 | Xifaxan |
| Biohaven Pharmaceutical Holding Company LTD. | $18.55 | 2022 | |
| Lucid Diagnostics INC. | $17.25 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.20 | 2021 | |
| Corium, LLC | $14.67 | 2024 | Azstarys |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $14.61 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $14.56 | 2021 | |
| Nestle Healthcare Nutrition INC. | $14.52 | 2021 | |
| Seqirus USA INC | $14.43 | 2024 | Flucelvax, Fluad |
| Sk Life Science, INC. | $14.19 | 2021 | |
| Halozyme INC | $13.35 | 2023 | |
| Exact Sciences Corporation | $13.24 | 2024 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $12.46 | 2019 | |
| Glaxosmithkline, LLC. | $11.65 | 2022 | |
| Ironshore Pharmaceuticals INC. | $11.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Leskie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.